Funded Tech Companies

CytomX Therapeutics

Headquartered in San Francisco, CytomX Therapeutics is venture-backed, with investment from Fidelity Management & Research Company, Deerfield Capital and Tekla Capital Management.

Company Overview

Contact Information

Company Background Information

Overview

CytomX (NASDAQ: CTMX) is unlocking the potential of antibody therapeutics in oncology by developing a novel therapeutic antibody class of highly targeted Probody therapeutics.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/8/2015

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Sean McCarthy

        

Chief Scientific Officer

Michael Kavanaugh

        

Vice President

Alison Joly

        

VP - Human Resources

Danielle Olander

        

VP - Manufacturing

Sridhar Viswanathan

        

Company Investors

• Fidelity Management & Research Company
• Deerfield Capital
• Tekla Capital Management
• Wellington Management Company
• Venrock
• Casdin Capital
• Cormorant Asset Management
• Perceptive Advisors
• Redmile Group
• Pfizer Venture Investments (Elaine Jones)
• Roche Venture Fund
• Third Rock Ventures (Neil Exter)
• Canaan Partners (Timothy Shannon)
• Third Rock Ventures (Charles Homcy)

Browse more funded tech companies:

Cytomos | CytoPherx

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary